Agronomics Ltd (ANIC)

Industry Asset Management


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

6.50p

Buy

7.20p

arrow-up0.15p (+2.19%)

Prices updated at 17 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Port Erin Biopharma Investments Ltd invests in biopharmaceutical sector. Its objective is to create value for shareholders through investing in companies that have potential to generate substantial revenues through development of biopharmaceutical drugs.

Income statement

20232024
--
--
25m-10m
--
22m-11m
25m-10m
Sales, General and administrative4m765,636
Interest expenses--
Provision for income taxes--
Operating expenses-25m10m
Income before taxes22m-11m
Net income available to common shareholders22m-11m
0.00316-0.01705
Net interest income1m1m
Advertising and promotion--
Net investment income, net-3m-2m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.00316-0.01705
Free cash flow per share-0.024-0.0159
Book value/share0.16940.1558
Debt equity ratio--

Balance sheet

20232024
Current assets38m21m
Current liabilities2m166,167
Total capital168m157m
Total debt--
Total equity168m157m
Total non current liabilities--
Loans--
Total assets170m157m
Total liabilities--
Cash and cash equivalents18m3m
Common stock993m1,009m

Cash flow

20232024
Cash at beginning of period31m18m
Cash dividends paid--
-24m-16m
Investments (gains) losses10m892,004
18m3m
Net income--
-24m-16m
--
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.